Pages that link to "Q37773255"
Jump to navigation
Jump to search
The following pages link to HER-2/neu as a target for cancer vaccines (Q37773255):
Displaying 33 items.
- Human mammaglobin in breast cancer: a brief review of its clinical utility (Q27001274) (← links)
- Multiorgan metastasis of human HER-2 breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor (Q28728165) (← links)
- A prophylactic vaccine for breast cancer? (Q34173578) (← links)
- Current status of autologous breast tumor cell-based vaccines (Q35154214) (← links)
- Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis (Q35157433) (← links)
- Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challenges (Q35838821) (← links)
- Overexpressed oncogenic tumor-self antigens (Q35886756) (← links)
- T cells sensitized with breast tumor progenitor cell vaccine have therapeutic activity against spontaneous HER2/neu tumors (Q38639083) (← links)
- HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model: Gene gun is superior to jet injector in inducing CTL responses and protective immunity (Q36476095) (← links)
- Targeted therapy for breast cancer prevention (Q37190825) (← links)
- Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide (Q37414561) (← links)
- Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2. (Q37691212) (← links)
- Vaccine-based clinical trials in ovarian cancer (Q37892583) (← links)
- AE37: a novel T-cell-eliciting vaccine for breast cancer (Q37927091) (← links)
- Prostate cancer vaccines in clinical trials (Q38036690) (← links)
- Future directions in cancer prevention (Q38059780) (← links)
- Therapeutic cancer vaccines: a long and winding road to success (Q38162261) (← links)
- Immune biomarkers: how well do they serve prognosis in human cancers? (Q38262757) (← links)
- Multi-therapeutic potential of autoantibodies induced by immune complexes trapped on follicular dendritic cells (Q38685586) (← links)
- Cancer-testis antigen expression is shared between epithelial ovarian cancer tumors (Q38708419) (← links)
- Epidermal growth factor receptor derived peptide vaccination to prevent lung adenocarcinoma formation: An in vivo study in a murine model of EGFR mutant lung cancer (Q38837187) (← links)
- A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit (Q40887427) (← links)
- Human CD3 T-Cells with the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells (Q41660817) (← links)
- Tumor-associated antigens for specific immunotherapy of prostate cancer (Q41977894) (← links)
- Immunologic biomarkers in prostate cancer: the AE37 paradigm (Q42738512) (← links)
- AE37 peptide vaccination in prostate cancer: a 4-year immunological assessment updates on a phase I trial (Q44644226) (← links)
- Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice (Q47946808) (← links)
- Virus-like particle display of HER2 induces potent anti-cancer responses. (Q52699878) (← links)
- CCL19 (ELC) improves TH1‐polarized immune responses and protective immunity in a murine Her2/neu DNA vaccination model (Q52890329) (← links)
- Overexpression of Epidermal Growth Factor Receptor (EGFR) and HER-2 in Bladder Carcinoma and Its Association with Patients' Clinical Features (Q57181580) (← links)
- A novel adjuvant Ling Zhi-8 for cancer DNA vaccines (Q82313385) (← links)
- Increased number of regulatory T cells (T-regs) in the peripheral blood of patients with Her-2/neu-positive early breast cancer (Q84515527) (← links)
- Re-expression of microRNA-4319 inhibits growth of prostate cancer via Her-2 suppression (Q88313848) (← links)